Advocacy intelligence hub — real-time data for patient organizations
Suzhou Sanegene Bio Inc. — PHASE2
Omeros Corporation — PHASE2
Apellis Pharmaceuticals, Inc. — PHASE3
Apellis Pharmaceuticals, Inc. — PHASE2
Region Skane — PHASE2
Novartis Pharmaceuticals — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Fernando C Fervenza, MD, M.D
Mayo Clinic
📍 ROCHESTER, MN
Gerald B Appel, MD, M.D
Columbia University
📍 NEW YORK, NY
Steve Whitaker, MD
Omeros Corporation
Diana Karpman
Region Skåne
Daniel Grigsby
University of Virginia
Lindsey A Chew
Duke University Medical Center
📍 HOUSTON, TX